Foster Group’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$247K Buy
4,281
+224
+6% +$12.9K 0.01% 274
2026
Q1
$246K Buy
4,057
+227
+6% +$13.2K 0.01% 236
2025
Q4
$207K Buy
+3,830
New +$184K 0.01% 282
2025
Q2
Sell
-4,210
Closed -$257K 266
2025
Q1
$257K Buy
+4,210
New +$245K 0.01% 177
2024
Q3
Sell
-6,787
Closed -$282K 207
2024
Q2
$282K Buy
6,787
+114
+2% +$5.1K 0.01% 166
2024
Q1
$362K Sell
6,673
-590
-8% -$30.1K 0.02% 143
2023
Q4
$422K Hold
7,263
0.03% 115
2023
Q3
$422K Buy
7,263
+600
+9% +$36.8K 0.03% 115
2023
Q2
$426K Buy
6,663
+149
+2% +$9.99K 0.03% 118
2023
Q1
$451K Sell
6,514
-427
-6% -$30.1K 0.03% 108
2022
Q4
$499K Buy
6,941
+148
+2% +$11.2K 0.04% 96
2022
Q3
$483K Buy
6,793
+341
+5% +$24.7K 0.04% 93
2022
Q2
$497K Buy
6,452
+1,320
+26% +$101K 0.04% 95
2022
Q1
$375K Buy
5,132
+11
+0.2% +$739 0.03% 101
2021
Q4
$319K Sell
5,121
-61
-1% -$3.58K 0.03% 111
2021
Q3
$307K Hold
5,182
0.03% 110
2021
Q2
$346K Buy
5,182
+78
+2% +$5.09K 0.04% 106
2021
Q1
$322K Hold
5,104
0.05% 100
2020
Q4
$312K Buy
+5,104
New +$314K 0.06% 86

Other funds holding BMY

Foster Group's BMY Position: Q2 2026 in Review

Foster Group increased its Bristol-Myers Squibb (BMY) stake by 5.5% in Q2 2026, buying an estimated $12.9K and bringing the position to 4,281 shares worth $247K. The position accounts for 0.01% of the portfolio, ranked #274.

Foster Group first reported a position in BMY in Q4 2020 and has held it in 19 quarters since. The position peaked at $499K in Q4 2022. 440 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Foster Group held 4,281 shares of Bristol-Myers Squibb worth $247K as of Q2 2026.
  • Foster Group bought 224 Bristol-Myers Squibb shares in Q2 2026, an estimated $12.9K.
  • Bristol-Myers Squibb made up 0.01% of Foster Group's portfolio in Q2 2026, its #274 holding.
  • Foster Group first reported a position in Bristol-Myers Squibb in Q4 2020 and has held it in 19 quarters since.
  • Foster Group's Bristol-Myers Squibb position peaked at $499K in Q4 2022.
  • 440 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Foster Group's 13F filing for Q2 2026, filed 7 Jul 2026.